can increase muscle mass and consequently the muscle volume available for the uptake of glucose from blood ( 10 ) . In T2DM patients, resistance exercise reduces insulin resistance and glycosylated hemoglobin (HbA 1c ; [ 11 ] ) .
Insulin is a potent stimulator of skeletal muscle protein anabolism, the specifi c mechanism by which insulin exerts its effects in human skeletal muscle is controversial. For example, several studies have reported insulin to have an inhibitory effect on muscle protein breakdown ( 12 ) , whereas others have shown insulin to have a direct stimulatory effect on muscle protein synthesis ( 13 ) . Insulin resistance might therefore negatively affect muscle protein metabolism if insulin signaling is compromised. Studies that addressed skeletal muscle amino acid metabolism in patients with T2DM showed mixed results, some reported that whole-body protein turnover was not impaired ( 14 ) , wh ereas others showed that whole-body proteolysis is signifi cantly elevated in patients with T2DM ( 15 ) .
Very few studies have investigated the effects of resistance exercise on muscle mass and muscle function in patients with impaired glucose metabolism ( 16 , 17 ) , particularly in comparison with healthy elderly controls ( 11 ) . Blunted anabolic response of muscle to insulin is considered to be associated with lower skeletal muscle mass during aging ( 18 ) . Therefore, patients with impaired glucose metabolism may gain less muscle mass, muscle strength , and muscle function during a resistance exercise program than healthy elderly controls.
Previously, our group investigated the effects of a 12-week resistance exercise program on body composition, muscle strength , and functional outcomes in Icelandic elderly participants ( 19 ) . The resistance training program had a positive effect on muscle strength and led to a significant improvement in physical function and health-related quality of life.
The present study focused on the associations between impaired glucose metabolism, muscle strength, physical function , and resistance exercise in elderly Icelanders. The aims were (i) to investigate whether impaired glucose metabolism at baseline predicts changes in glucose metabolism during a 12-week resistance exercise program and (ii) to investigate whether impaired glucose metabolism at baseline predicts changes in muscle strength or physical function during a 12-week resistance exercise program.
M ethods

Subjects
Participants ( N = 237) were recruited by advertisements posted in the Reykjavik area ( 19 ) . Exclusion criteria were age younger than 65 years, low cognitive function (MiniMental State Examination ≤ 19 points ; [ 20 ] ) , evidence of uncontrolled coronary heart disease, major musculoskeletal disease, and pharmacological interventions with exogenous testosterone or other drugs known to infl uence muscle mass. Furthermore, participants had to be free of other disorders that could affect their ability to complete the training and testing. Enrolled participants were apparently healthy, although some had milder forms of hypertension, hyperlipidemia, T2DM , or other diseases associated with age. When cardiovascular disease symptoms were detected during screening, participants were encouraged to contact their physician for medical clearance. The study was approved by the Icelandic National Bioethics Committee (VSNb2008060007/03-15) , and informed written consent was obtained from all participants.
Study design and intervention. -The current study is a part of a randomized and controlled dietary intervention study originally designed to investigate the effects of different dietary supplement drinks on the effi cacy of resistance training among older adults. The 12-week resistance exercise program was designed to increase strength and muscle mass of all major muscle groups. All data were obtained at baseline and again at the end of the study period. Glucose metabolism status was not a selection criteria for the weight training trial , and the group designation used in the analyses conducted in the current article was not part of the original study.
Participants exercised for three nonconsecutive days per week for 12 weeks in groups of 20 -30 individuals. Each session was supervised by study staff, an athletic trainer, and occasionally a physical therapist. Ten different exercises were performed in weight machines during each training session; seated leg extension, seated leg curl, seated leg press, seated chest fl y, seated row, seated pull-down, seated biceps curl, seated triceps curl, seated lower back extension, and seated abdominal curl. Before the intervention started, 1-repetition maximum (1-RM) was assessed using weight machines and by progressively increasing the weight lifted until the participant failed to lift the weight. Prior to the 1-RM test, most of the participants were not familiar with the weight machine equipment. The fi rst week of the 12-week training period was used to teach correct exercise techniques at lower loads (60% of 1-RM). Thereafter, resistance training involved three sets, where each exercise was repeated six to eight times, at 75 % -80% of their 1-RM. The training load was systematically increased by 5 % -10% each week in order to keep the number of repetitions per set between six and eight. Each exercise session started with a moderate, 10-to 15-minute aerobic warm-up on a treadmill or a stationary exercise bicycle, after which resistance training with weight machines was performed. Stretching exercises were performed at the end of each session.
Participants were randomly assigned to one of three different dietary supplements that were consumed after each training session. The dietary supplements were ( i ) a whey protein drink (20 g whey protein isolate + 20 g carbohydrates), ( ii ) a milk protein drink (20 g milk protein isolate + 20 g carbohydrates) , or ( iii ) a carbohydrate drink (40 g carbohydrates).
Body C omposition
Body composition, ie, lean body mass and fat mass, was assessed by a dual-energy x-ray absorptiometer (DXA, Hologic QDR-2000 plus, Hologic Inc., Waltham, MA). The DXA measurements were done at the Icelandic Heart Association, Kopavogur, Iceland. Body weight was measured in light underwear on a calibrated scale (model no. 708 ; Seca, Hamburg, Germany). The participants ' height was measured with a calibrated stadiometer (model no. 206; Seca). Body mass index was calculated from height and weight ( kg/m 2 ) .
Physical F unction and M uscle S trength
Participants underwent testing of physical function, including the t imed u p and g o test and a 6 -minute walk for distance in meters.
During the timed up and go test test , the participant , wearing ordinary footwear and using customary walking aids if necessary, was instructed to rise from a chair with a seat height of 43 cm, walk 3 m, turn around, return , and sit down again ( 21 ) .
The 6-minute walk for distance ( 22 ) was conducted according to the guidelines from the American Thoracic Society ( 23 ) and was performed indoors, along a fl at, straight, and enclosed corridor with a hard surface.
To evaluate muscle strength, grip strength and knee extensor muscle strength were measured.
Quadriceps strength (maximum voluntary isometric contraction) was tested with an isokinetic dynamometer (Kin-Com 500H Chattanooga). The participants performed three submaximal trials and then performed four maximum voluntary isometric contraction tests for 5 seconds each, with a 50-second rest between tests. The greatest output was recorded as the peak torque expressed in Newtons (N). Normalized quadriceps strength was calculated as the greatest quadriceps output ( N ) divided by lean mass (kg) as measured with DXA.
Grip strength was measured with a hydraulic hand dynamometer (Baseline Baseline Evaluations Corporation), and the maximal grip strength of three trials was registered as the participant ' s grip force in kilos (kg).
Questionnaire
Information on demographic variables, physical activity (frequency, type, and duration) , and medication was collected using questionnaires ( t hese were self reports, however, when the participants did not know how to fi ll out the questionnaire, they received help from the staff). For the statistical analysis , physical activity was categorized as less than 30 minutes/day and more than or equal to 30 minutes/day (linear models, see below). Demographic variables and medication were not associated to the outcome variables , and thus they were not included in the fi nal models.
Biochemical M easurements
Participants were instructed to avoid strenuous exercise and alcohol consumption the day before the drawing of fasting blood samples at baseline and endpoint. The blood samples were centrifuged and the serum was stored at − 80°C for subsequent analysis of blood glucose (mmol/ L ), insulin (mU/L), HbA 1c (%) , and plasma triacylglycerol (mmol/ L ).
Insulin was measured with electrochemiluminescence immunoassay on a Modular Analytics E170 system from Roche Diagnostics (Manheim, Germany). Plasma triacylglycerol and glucose were analyzed using an enzymatic colorimetric assay and an automated analyzer (Hitachi 911; Roche Diagnostics). HbA 1c was measured using a chromatographicspectrophotometric assay.
Participants were grouped according to impairment of glucose metabolism into ( i ) healthy participants , ( ii ) participant s with prediabetes , and ( iii ) participant s diagnosed with T2DM. Participant s with prediabetes were defi ned as having impaired fasting glucose levels, from 100 mg/d L (5.6 mmol/ L ) to 125 mg/d L (6.9 mmol/ L ; [ 24 ] ) .
Statistical A nalysis
The data were entered into the SPSS statistical package, version 18.0 (SPSS, Chicago, IL). Data are described as the mean ± standard deviation. Data were checked for normality, using the Kolmogorov -Smirnov test and nonparametric tests were used on data not normally distributed. The independent-samples t test and Mann -Whitney U test were used to calculate the differences between individuals who dropped out and those who completed the study. The paired t test and paired Wilcoxon test (nonparametric) were used to evaluate differences between the baseline and endpoint. Pearson correlation coeffi cient r was used to investigate associations between anthropometric changes or gains in strength or function and improvements in glucose metabolism observed after the intervention.
Linear M odels
Linear models were used to calculate differences in the outcomes between the three groups. The models included fi xed factors (gender, group, physical activity category, and protein drink) and covariates (baseline value of the outcome variable and age). Results from the linear models are shown as parameter estimates, where the healthy and prediabetic participants were compared with the T2DM participants. Additionally, pair wise comparisons were done ( e stimated marginal means with Bonferroni confi dence interval adjustment). The signifi cance level was set at p ≤ .05.
Retrospective power calculations showed that with the numbers of participants in the prediabetic and diabetic group , a difference of 0.5% HbA 1c and 0.8 mmol glucose can be detected as signifi cant (power = 0.8, signifi cance niveau = 0.05).
R esults
At baseline 237 (male = 98, female = 139, age range = 65 -92 y) participants started the 12-week program, and 213 (male = 91 and female = 122) participants completed the study. The dropout rate was 9%, and the reasons for dropping out were illness and falls at home ( n = 18); some participants did not like the program ( n = 8), wh ereas others had to quit because of previously diagnosed musculoskeletal problems ( n = 3) and two participants did not have all results from the serum analysis and were excluded. Dropouts were significantly older at baseline ( p = .001), had less quadriceps strength ( p = .002) , and grip strength ( p = .016), and there was no gender difference. Dropouts had less 6-minute walk for distance ( p = .006) and slower timed up and go test ( p = .003). A majority (82%) of the participants reported regular physical activity at baseline and two thirds reached the recommended level of 30 minutes per day ( 25 ) . According to Kruskal -Wallis test, the distribution of physical activity (min/week) was equal across groups ( p = .790). Reported physical activity was primarily moderate aerobic exercise, and only three male participants had engaged in resistance exercise in the year prior to the start of the study.
At baseline, 7.2% of participants had T2DM ( n = 17; male = 9, female = 8), and additional 8.4% of participants were prediabetic ( [ 21 ] ; n = 20; male = 9, female = 11). No difference was found in gender, Mini-Mental State Examination , or in sociodemographic factors between diabetic elderly participants and prediabetic or healthy participants at baseline. The characteristics of the three groups are shown in Table 1 .
After the intervention , all groups exhibited signifi cant changes in muscle strength and physical function ( Table 1 ) . According to linear models, no difference was found in the degree of changes seen in muscle strength or physical function ( Table 2 ) between healthy participants and participants with prediabetes or T2DM.
According to bivariate analysis , only glucose improved signifi cantly in the prediabetic group; glucose and triacylglycerol improved signifi cantly in the healthy group; whereas no serum parameter improved signifi cantly in the T2DM group ( Table 1 ) . According to the linear models , healthy and prediabetic participants had (borderline) signifi cantly lower endpoint HbA 1C and glucose (both corrected for baseline values) than T2DM participants ( Table 3 ) . Differences in insulin and triacylglycerol were not signifi cant between groups (model not shown).
No association was found between increased muscle mass, quadriceps strength , or physical function and improved glucose control during the intervention (data not shown).
D iscussion
In the present study , we investigated the effects of resistance training on muscle mass, muscle strength, physical function , and glucose metabolism in three groups of healthy, prediabetic , and T2DM older people.
The most important fi nding of our study is that the participants of the three groups increased muscle mass, muscle strength , and physical function to a similar degree after the intervention. Although studies have reported that resistance training improves muscular outcomes in diabetic older adults ( 16 , 17 , 26 ) , a recently published study indicated that individuals with T2DM gain less strength than non-T2DM participants ( 11 ) . The authors explained this difference with impairment in the basal hypothalamic-pituitary-adrenal axis function as a limiting factor in strength development in older T2DM adults ( 11 ) . However, in the study by Holten and colleagues ( 7 ), participants in 6-week strength training program, the increase in maximal leg muscle strength were similar between the T2DM and healthy older men , which is in line with our result. In general, muscle weakness in T2DM has been explained by anabolic resistance due to insulin resistance or neuropathy ( 18 , 27 ) . Our results do not support a negative effect of impaired glucose metabolism on training effi cacy in older adults.
According to bivariate analysis , there were some significant changes in blood variables after the 12-week intervention, ie, glucose (prediabetic and healthy participants) and triacylglycerol (healthy participants). No signifi cant changes in serum parameters were seen in the T2DM group. According to the linear models , healthy and prediabetic participants had (or tended to have) lower glucose and HbA1c compared with T2DM participants. All participants in the T2DM group were taking either oral hypoglycemic medication or insulin during the intervention, resulting into fasting glucose at baseline below 8 mmol/L, which can explain why we did not see any effects of the intervention on parameters Table 2 . Parameter E stimates F rom a L inear M odel for the P rediction of N ormalized Q uadriceps S trength and P hysical F unction (endpoint) of glucose metabolism. In a similar study in T2DM participants, a 29% decrease in fasting glucose was observed after 4 months of resistance exercise (compared with baseline). Although the patients received drug therapy , their baseline glucose was more than 11 mmol/L, which possibly explains the huge improvements after training ( 28 ) . Other studies using a combination of resistance and endurance exercise have also reported improvements in fasting glucose after training in T2DM participants with baseline fasting glucose of 9.2 and 12.0 mmol/ L ( 29 , 30 ) . Several studies ( 16 , 31 ) , although not all ( 32 ) , have shown a decline in HbA 1c in patients with T2DM after resistance exercise spanning from several weeks to several months. A recent meta-analysis done by Strasser and colleagues ( 33 ) showed that the greatest improvements in glycemic control occurred when HbA 1c was more than 8.0% at baseline. This is higher than the average HbA 1c in our T2DM group (6.8% at baseline) and could explain why no effect was seen on HbA 1c among T2DM participants after the intervention.
Our data showed no association between increased muscle mass, quadriceps strength , or physical function and improved glucose control during the intervention. A possible reason is that improvement in glycemic control is not dependent upon change in muscle mass. On the contrary, changes in glucose metabolism are rather the consequence of internal alterations in the muscle than changes in muscle size ( 7 , 8 ) .
Limitation
The study participants were well-functioning older people who were more physically active and healthier than the average older individual and thus not representative of the general population of this age. Furthermore, the study period was only 12 weeks, which may have limited the participants ' ability to demonstrate larger gains in muscle mass. The number of prediabetic and T2DM participants was low, which limited statistical power to detect statistically signifi cant differences. However, according to the linear models , our study still detected signifi cant differences in blood parameters between the groups but not in muscular strength or physical function, where the actual endpoint differences between groups were small and did not seem clinically relevant, ie, 0.2 sec onds for timed up and go test , 6 m in 6-minute walk for distance , and 0.3 N /kg in quadriceps strength/lean body mass.
C onclusion s
A 12-week resistance exercise program can improve strength and physical function in healthy, prediabetic , and T2DM elderly participant s to a similar degree. However, according to our data , T2DM participants do not experience favorable changes in fasting glucose or HbA 1C . 
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